TY - JOUR
T1 - MCOLN1/TRPML1 finely controls oncogenic autophagy in cancer by mediating zinc influx
AU - Qi, Jiansong
AU - Xing, Yanhong
AU - Liu, Yucheng
AU - Wang, Meng Meng
AU - Wei, Xiangqing
AU - Sui, Zhongheng
AU - Ding, Lin
AU - Zhang, Yang
AU - Lu, Chen
AU - Fei, Yuan Hui
AU - Liu, Nan
AU - Chen, Rong
AU - Wu, Mengmei
AU - Wang, Lijuan
AU - Zhong, Zhenyu
AU - Wang, Ting
AU - Liu, Yifan
AU - Wang, Yuqing
AU - Liu, Jiamei
AU - Xu, Haoxing
AU - Guo, Feng
AU - Wang, Wuyang
N1 - Funding Information:
This work was supported by the National Natural Science Foundation of China [81772559]; National Natural Science Foundation of China [82071225]; National Natural Science Foundation of China [81971212]. This work was supported by National Natural Science Foundation of China (NSFC) grants (81772559 to W. W; 81971212 to F. G; 81600967 to C. L), NSF grants of the Jiangsu Province (BK20170262 to W. W), Jiangsu Specially-Appointed Professor award to W.W, Jiangsu Province Innovative and Entrepreneurial Talent program to W.W and Jiangsu Province Innovative and Entrepreneurial Team program to W.W. We are grateful to Drs. Hong Zhang (National Institute of Biological Sciences, Beijing, China), Li Yu (School of Life Sciences, Tsinghua University), Edward A Fon (Department of Neurology and Neurosurgery, McGill University), Amy Kiger (Department of Cell & Developmental Biology, University of California, San Diego), Ling Chen (Guangzhou institutes of biomedicine and health, Chinese academy of sciences), and Qiming Sun (School of Basic Medical Sciences, Zhejiang University) for sharing the plasmids and cell lines. We are grateful to Dr. Hailey Jansen (Libin Cardiovascular Institute, University of Calgary, Canada) for critical reading through the manuscript and appreciate the encouragement and helpful comments from other members of the Wang laboratory.
Funding Information:
This work was supported by National Natural Science Foundation of China (NSFC) grants (81772559 to W. W; 81971212 to F. G; 81600967 to C. L), NSF grants of the Jiangsu Province (BK20170262 to W. W), Jiangsu Specially-Appointed Professor award to W.W, Jiangsu Province Innovative and Entrepreneurial Talent program to W.W and Jiangsu Province Innovative and Entrepreneurial Team program to W.W. We are grateful to Drs. Hong Zhang (National Institute of Biological Sciences, Beijing, China), Li Yu (School of Life Sciences, Tsinghua University), Edward A Fon (Department of Neurology and Neurosurgery, McGill University), Amy Kiger (Department of Cell & Developmental Biology, University of California, San Diego), Ling Chen (Guangzhou institutes of biomedicine and health, Chinese academy of sciences), and Qiming Sun (School of Basic Medical Sciences, Zhejiang University) for sharing the plasmids and cell lines. We are grateful to Dr. Hailey Jansen (Libin Cardiovascular Institute, University of Calgary, Canada) for critical reading through the manuscript and appreciate the encouragement and helpful comments from other members of the Wang laboratory.
Publisher Copyright:
© 2021 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2021
Y1 - 2021
N2 - Macroautophagy/autophagy is elevated to ensure the high demand for nutrients for the growth of cancer cells. Here we demonstrated that MCOLN1/TRPML1 is a pharmaceutical target of oncogenic autophagy in cancers such as pancreatic cancer, breast cancer, gastric cancer, malignant melanoma, and glioma. First, we showed that activating MCOLN1, by increasing expression of the channel or using the MCOLN1 agonists, ML-SA5 or MK6-83, arrests autophagic flux by perturbing fusion between autophagosomes and lysosomes. Second, we demonstrated that MCOLN1 regulates autophagy by mediating the release of zinc from the lysosome to the cytosol. Third, we uncovered that zinc influx through MCOLN1 blocks the interaction between STX17 (syntaxin 17) in the autophagosome and VAMP8 in the lysosome and thereby disrupting the fusion process that is determined by the two SNARE proteins. Furthermore, we demonstrated that zinc influx originating from the extracellular fluid arrests autophagy by the same mechanism as lysosomal zinc, confirming the fundamental function of zinc as a participant in membrane trafficking. Last, we revealed that activating MCOLN1 with the agonists, ML-SA5 or MK6-83, triggers cell death of a number of cancer cells by evoking autophagic arrest and subsequent apoptotic response and cell cycle arrest, with little or no effect observed on normal cells. Consistent with the in vitro results, administration of ML-SA5 in Patu 8988 t xenograft mice profoundly suppresses tumor growth and improves survival. These results establish that a lysosomal cation channel, MCOLN1, finely controls oncogenic autophagy in cancer by mediating zinc influx into the cytosol. Abbreviation: Abbreviations: 3-MA: 3-methyladenine; AA: amino acid; ATG12: autophagy related 12; Baf-A1: bafilomycin A1; BAPTA-am: 1,2-bis(2-aminophenoxy)ethane-N, N,N’,N’-tetraacetic acid tetrakis-acetoxymethyl ester; co-IP: coimmunoprecipitaion; CQ: chloroquine; DMEM: Dulbecco’s Modified Eagle Medium; FBS: fetal bovine serum; GAPDH: glyceraldehyde- 3-phosphate dehydrogenase; HCQ: hydroxychloroquine; HEK: human embryonic kidney; LAMP1: lysosomal associated membrane protein 1; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MCOLN1/TRPML1: mucolipin TRP cation channel 1; MTORC1: mechanistic target of rapamycin kinase complex 1; NC: negative control; NRK: normal rat kidney epithelial cells; PBS: phosphate-buffered saline; PtdIns3K: phosphatidylinositol 3-kinase; RPS6KB/S6K: ribosomal protein S6 kinase B; shRNA: short hairpin RNA; siRNA: short interfering RNA; SNARE: soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptor; SQSTM1/p62: sequestosome 1; STX17: syntaxin 17; TPEN: N,N,N’,N’-tetrakis(2-pyridylmethyl)ethylenediamine; TTM: tetrathiomolybdate; ULK1: unc-51 like autophagy activating kinase 1; VAMP8: vesicle associated membrane protein 8; Zn2+: zinc.
AB - Macroautophagy/autophagy is elevated to ensure the high demand for nutrients for the growth of cancer cells. Here we demonstrated that MCOLN1/TRPML1 is a pharmaceutical target of oncogenic autophagy in cancers such as pancreatic cancer, breast cancer, gastric cancer, malignant melanoma, and glioma. First, we showed that activating MCOLN1, by increasing expression of the channel or using the MCOLN1 agonists, ML-SA5 or MK6-83, arrests autophagic flux by perturbing fusion between autophagosomes and lysosomes. Second, we demonstrated that MCOLN1 regulates autophagy by mediating the release of zinc from the lysosome to the cytosol. Third, we uncovered that zinc influx through MCOLN1 blocks the interaction between STX17 (syntaxin 17) in the autophagosome and VAMP8 in the lysosome and thereby disrupting the fusion process that is determined by the two SNARE proteins. Furthermore, we demonstrated that zinc influx originating from the extracellular fluid arrests autophagy by the same mechanism as lysosomal zinc, confirming the fundamental function of zinc as a participant in membrane trafficking. Last, we revealed that activating MCOLN1 with the agonists, ML-SA5 or MK6-83, triggers cell death of a number of cancer cells by evoking autophagic arrest and subsequent apoptotic response and cell cycle arrest, with little or no effect observed on normal cells. Consistent with the in vitro results, administration of ML-SA5 in Patu 8988 t xenograft mice profoundly suppresses tumor growth and improves survival. These results establish that a lysosomal cation channel, MCOLN1, finely controls oncogenic autophagy in cancer by mediating zinc influx into the cytosol. Abbreviation: Abbreviations: 3-MA: 3-methyladenine; AA: amino acid; ATG12: autophagy related 12; Baf-A1: bafilomycin A1; BAPTA-am: 1,2-bis(2-aminophenoxy)ethane-N, N,N’,N’-tetraacetic acid tetrakis-acetoxymethyl ester; co-IP: coimmunoprecipitaion; CQ: chloroquine; DMEM: Dulbecco’s Modified Eagle Medium; FBS: fetal bovine serum; GAPDH: glyceraldehyde- 3-phosphate dehydrogenase; HCQ: hydroxychloroquine; HEK: human embryonic kidney; LAMP1: lysosomal associated membrane protein 1; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MCOLN1/TRPML1: mucolipin TRP cation channel 1; MTORC1: mechanistic target of rapamycin kinase complex 1; NC: negative control; NRK: normal rat kidney epithelial cells; PBS: phosphate-buffered saline; PtdIns3K: phosphatidylinositol 3-kinase; RPS6KB/S6K: ribosomal protein S6 kinase B; shRNA: short hairpin RNA; siRNA: short interfering RNA; SNARE: soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptor; SQSTM1/p62: sequestosome 1; STX17: syntaxin 17; TPEN: N,N,N’,N’-tetrakis(2-pyridylmethyl)ethylenediamine; TTM: tetrathiomolybdate; ULK1: unc-51 like autophagy activating kinase 1; VAMP8: vesicle associated membrane protein 8; Zn2+: zinc.
UR - http://www.scopus.com/inward/record.url?scp=85105049293&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105049293&partnerID=8YFLogxK
U2 - 10.1080/15548627.2021.1917132
DO - 10.1080/15548627.2021.1917132
M3 - Article
C2 - 33890549
AN - SCOPUS:85105049293
SN - 1554-8627
VL - 17
SP - 4401
EP - 4422
JO - Autophagy
JF - Autophagy
IS - 12
ER -